Europe’s medicines regulator has recommended approving the use of Moderna’s Covid vaccine in 12- to 17-year-olds, paving the way for it to become the second shot approved for adolescent use in the European Union.

“The use of the vaccine will be the same in adolescents as in people above 18 years. The vaccine produced a comparable antibody response to that seen in 18- to 25-year olds,” the European Medicines Agency (EMA) said.

In May, the EMA approved the Pfizer/BioNTech vaccine for use in 12 to 15-year-olds.